PXD101
-
Catalog number2480-25
-
PricePlease ask
-
Size25 mg
-
-
Alternative_name(E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide; Belinostat
-
DescriptionA potent histone deacetylase (HDAC) activity inhibitor. It inhibits HDAC activity in HeLa cell extracts with an IC₅₀ of 27 nM. Belinostat significantly increases acetylation of histones H3 and H4 and potently inhibits the growth of prostate cancer cell lines (IC₅₀ range from 0.5 to 2.5 µM) with cytotoxic activity preferentially against tumor cells.
-
CAS Number414864-00-9
-
Structure AvailableYes
-
Molecular FormulaC₁₅H₁₄N₂O₄S
-
Molecular Weight318.35
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (>50 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA potent histone deacetylase (HDAC) activity inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life24 months
-
PubChem CID6918638
-
SMILESC1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)C=CC(=O)NO
-
InChiInChI=1S/C15H14N2O4S/c18-15(16-19)10-9-12-5-4-8-14(11-12)22(20,21)17-13-6-2-1-3-7-13/h1-11,17,19H,(H,16,18)/b10-9+
-
InChi KeyNCNRHFGMJRPRSK-MDZDMXLPSA-N
-
MSDS AvailableYes
-
Gene target
-
Short namePXD101
-
Alternative namePXD101
-